Erik Selin: Strategic Investments and Leadership Roles in 2024

Erik Selin, the Swedish billionaire and CEO of Fastighets AB Balder, continues to make headlines in 2024 with strategic investments and prominent leadership roles. With a net worth of $4.6 billion, Selin’s influence extends across various industries, including real estate, medical technology, and innovative consumer products. His actions this year underscore his commitment to driving growth and innovation across diverse sectors.

In October 2024, Selin increased his stake in the medical technology firm Bonesupport. Through his company Erik Selin Fastigheter, he now owns 9.07% of the company’s capital and 9.18% of the votes, solidifying his position as the second-largest shareholder after Healthcap. This investment highlights his confidence in Bonesupport’s potential to revolutionize the medical technology industry. The company is known for its innovative solutions in bone infection treatment and skeletal reconstruction, making it a unique player in its field.

Earlier in the year, Selin assumed the role of chairman at Multi4 Medical AB, a company focused on pioneering automatic technologies for cancer diagnosis and treatment. Multi4 Medical has developed a patented instrument for treating bladder cancer that allows for outpatient procedures completed in just 20 minutes. Selin’s leadership is expected to guide the company through the crucial stages of market introduction and adoption, reinforcing his reputation as a strategic thinker with a focus on transformative innovations.

Selin’s strategic investments also extend to the financial services sector. In 2022, he acquired a 20% stake in Alektum Group, a debt collection firm operating in 14 European markets. This move aligns with Alektum Group’s growth ambitions and benefits from Selin’s extensive professional network and entrepreneurial expertise. His involvement is anticipated to strengthen the company’s position in the highly competitive European market.

In another noteworthy move, Selin invested 4.4 million SEK in Sting Free AB, a company producing innovative nicotine pouches. With a patented design that includes a protective shield to reduce gum irritation, Sting Free AB addresses a common concern among users, promoting better oral health. Selin’s investment positions him as the second-largest shareholder, reflecting his interest in consumer health products and sustainable solutions.

Despite his diverse portfolio, Selin remains firmly rooted in real estate through his role as CEO of Fastighets AB Balder. Since founding the company in 2005, he has transformed it into one of Sweden’s leading real estate firms. Balder’s portfolio includes 50 hotels, making it one of the largest hotel owners in the country. With a focus on residential properties, the company has built a reputation for stability and long-term growth under Selin’s stewardship.

Erik Selin’s activities in 2024 highlight his ability to identify opportunities across industries and leverage his expertise to drive innovation and growth. From healthcare and technology to real estate and consumer products, Selin’s investments and leadership roles exemplify his strategic vision. As he continues to expand his influence, Selin remains a key figure in shaping the future of the industries he engages with.